1.
|
9 p, 227.9 KB |
Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease : Results from the MOPEAD project
/
Boada, Mercè (Universitat Internacional de Catalunya) ;
Rodrigo, Adrián (GMV SECURE E SOLUTIONS) ;
Jessen, Frank (Faculty of Medicine and University Hospital Cologne) ;
Wimblad, Bengt (Karolinska Univ Hospital) ;
Kramberger, Milica G. (University of Ljubljana) ;
Visser, Pieter Jelle (Maastricht University) ;
Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron) ;
Rodríguez-Gomez, Octavio (Universitat Internacional de Catalunya) ;
Ciudin, Andreea (Hospital Universitari Vall d'Hebron) ;
Georges, Jean (Alzheimer Europe) ;
Dumas, Annete (ASDM Consulting) ;
Maguire, Peggy (European Institute of Women's Health) ;
Krivec, David (Zdruzenje Spomincica) ;
Wimo, Anders (Karolinska Institutet (Estocolm, Suècia)) ;
Valero, Sergi (Instituto de Salud Carlos III) ;
Alegret, Montserrat (Instituto de Salud Carlos III) ;
Jamilis, Laura (GMV SECURE E SOLUTIONS) ;
Zwan, Marissa (Vrije Universiteit Amsterdam) ;
Sannemann, Lena (Faculty of Medicine and University Hospital Cologne) ;
Arrufat, Jordi (EAP Sarrià-Vallvidrera-Les Planes) ;
Stomrud, Erik (Region Kalmar County) ;
Johansson, Gunilla (Karolinska Institutet (Estocolm, Suècia)) ;
Glaysher, Bridget (Modus Research and Innovation Limited) ;
Stewart, Neil (Modus Research and Innovation Limited) ;
Belger, Mark (Eli Lilly and Company (Lilly UK)) ;
Iradier, Fatima (Eli Lilly and Company) ;
Campo, Laura (Eli Lilly and Company) ;
Universitat Autònoma de Barcelona
The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived to explore innovative complementary strategies to uncover hidden prodromal and mild Alzheimer's disease (AD) dementia cases and to raise awareness both in the general public and among health professionals about the importance of early diagnosis. [...]
2021 - 10.1002/alz.12441
Alzheimer's & Dementia, Vol. 18 (july 2021) , p. 1119-1127
|
|
2.
|
8 p, 767.0 KB |
What else can we do to prevent diabetic retinopathy?
/
Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron) ;
Hernández, Cristina (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
The classical modifiable factors associated with the onset and progression of diabetic retinopathy are the suboptimal control of blood glucose levels and hypertension, as well as dyslipidaemia. However, there are other less recognised modifiable factors that can play a relevant role, such as the presence of obesity or the abnormal distribution of adipose tissue, and others related to lifestyle such as the type of diet, vitamin intake, exercise, smoking and sunlight exposure. [...]
2023 - 10.1007/s00125-023-05940-5
Diabetologia, Vol. 66 (june 2023) , p. 1614-1621
|
|
3.
|
19 p, 12.6 MB |
Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline
/
Little, Karis (Queen's University Belfast) ;
Singh, Aditi (Queen's University Belfast) ;
Del Marco, Angel (Instituto de Investigacion e Innovacion en Ciencias Biomedicas de la Provincia de Cadiz) ;
Llorián-Salvador, María (Hospital Universitari Vall d'Hebron) ;
Vargas-Soria, Maria (Instituto de Investigacion e Innovacion en Ciencias Biomedicas de la Provincia de Cadiz) ;
Turch-Anguera, Mireia (Hospital Universitari Vall d'Hebron) ;
Solé Piñol, Montserrat (Hospital Universitari Vall d'Hebron) ;
Bakker, Noëlle (Amsterdam UMC location University) ;
Scullion, Sarah (Queen's University Belfast) ;
Comella i Carnicé, Joan Xavier 1963- (Hospital Universitari Vall d'Hebron) ;
Klaassen, Ingeborg (Amsterdam UMC location University of Amsterdam) ;
Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron) ;
Garcia-Alloza, Monica (Instituto de Investigacion e Innovacion en Ciencias Biomedicas de la Provincia de Cadiz) ;
Tiwari, Vijay K. (Odense University Hospital (Dinamarca)) ;
Stitt, Alan W. (Queen's University Belfast) ;
Universitat Autònoma de Barcelona
Type 2 diabetes is associated with increased risk of cognitive decline although the pathogenic basis for this remains obscure. Deciphering diabetes-linked molecular mechanisms in cells of the cerebral cortex could uncover novel therapeutic targets. [...]
2023 - 10.1007/s00125-023-05935-2
Diabetologia, Vol. 66 (june 2023) , p. 1557-1575
|
|
4.
|
9 p, 300.4 KB |
Protein Supplementation with Short Peptides Prevents Early Muscle Mass Loss after Roux-en-Y-Gastric Bypass
/
Comas Martínez, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Fidilio, Enzamaria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Palmas Candia, Fiorella (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cordero-Vazquez, Efrain (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Hernández, Irene (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vilallonga, Ramon (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Burgos Peláez, Rosa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vila-Martí, Anna (Universitat de Vic, Universitat Central de Catalunya (UVic-UCC)) ;
Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ciudin, Andreea (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
A significant reduction in fat-free mass (FFM) following bariatric surgery (BS) has been reported, and adequate protein intake is recommended for FFM preservation. Current guidelines of nutritional management after BS recommend complex protein (CP) compounds. [...]
2022 - 10.3390/nu14235095
Nutrients, Vol. 14 (december 2022)
|
|
5.
|
|
6.
|
13 p, 1.4 MB |
Risk Factors, Radiological and Clinical Outcomes in Subclinical and Clinical Pituitary Apoplexy
/
Biagetti, Betina (Hospital Universitari Vall d'Hebron) ;
Sarria-Estrada, Silvana (Hospital Universitari Vall d'Hebron) ;
Cordero Asanza, Esteban (Hospital Universitari Vall d'Hebron) ;
Chaachou-Charradi, Anas (Hospital Universitari Vall d'Hebron) ;
Ng-Wong, Yiken Karelys (Hospital Universitari Vall d'Hebron) ;
Cicuendez, Marta (Hospital Universitari Vall d'Hebron) ;
Hernandez, Irene (Hospital Universitari Vall d'Hebron) ;
Rojano-Toimil, Alba (Hospital Universitari Vall d'Hebron) ;
Costa, Pilar (Hospital Universitari Vall d'Hebron) ;
Martinez-Saez, Elena (Hospital Universitari Vall d'Hebron) ;
Casteràs, Anna (Hospital Universitari Vall d'Hebron) ;
Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Pituitary apoplexy (PA) can be symptomatic, namely acute apoplexy (APA), or asymptomatic or subclinical (SPA). To describe the clinical characteristics and evolution of the patients with APA compared to SPA Patients and methods: Retrospective, longitudinal database analysis. [...]
2022 - 10.3390/jcm11247288
Journal of clinical medicine, Vol. 11 (december 2022)
|
|
7.
|
|
8.
|
12 p, 1.2 MB |
Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus : Findings from Clinical and Experimental Studies
/
Alcubierre, Nuria (Avantmèdic (LLeida)) ;
Granado-Casas, Minerva (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Bogdanov, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ramos, Hugo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Castelblanco, Esmeralda (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Real, Jordi (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Rubinat, Esther (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Traveset, Alicia (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Hernández, Marta (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Jurjo, Carmen (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Vioque, Jesús (Instituto de Salud Carlos III) ;
Navarrete-Muñoz, Eva Maria (Instituto de Investigación Sanitaria y Biomédica de Alicante) ;
Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
The aim of this study was to assess the potential benefits of caffeine intake in protecting against the development of diabetic retinopathy (DR) in subjects with type 2 diabetes (T2D). Furthermore, we tested the effect of topical administration of caffeine on the early stages of DR in an experimental model of DR. [...]
2023 - 10.3390/nu15051169
Nutrients, Vol. 15 (february 2023)
|
|
9.
|
15 p, 1.0 MB |
Insights into Insulin Resistance and Calcification in the Myocardium in Type 2 Diabetes : A Coronary Artery Analysis
/
Martín-Saladich, Queralt (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Aguadé-Bruix, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Simó-Servat, Olga (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Aparicio-Gómez, Carolina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ramirez-Serra, Clara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pizzi, María Nazarena (Universitat de Barcelona. Departament de Medicina) ;
Roque, Albert (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
González Ballester, Miguel A. (Universitat Pompeu Fabra) ;
Herance, José Raul (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Type 2 diabetes (T2D) is responsible for high incidence of cardiovascular (CV) complications leading to heart failure. Coronary artery region-specific metabolic and structural assessment could provide deeper insight into the extent of the disease and help prevent adverse cardiac events. [...]
2023 - 10.3390/ijms24043250
International journal of molecular sciences, Vol. 24 (february 2023)
|
|
10.
|
|